Highly Sensitive Enumeration of Circulating Tumor Cells in Lung Cancer Patients Using a Size-Based Filtration Microfluidic Chip.
Ting Huang,Chun-Ping Jia,Jun-Yang,Wen-Jie Sun,Wen-Tao Wang,Hong-Lian Zhang,Hui Cong,Feng-Xiang Jing,Hong-Ju Mao,Qing-Hui Jin,Zhen Zhang,Ying-Jie Chen,Gang Li,Guo-Xin Mao,Jian-Long Zhao
DOI: https://doi.org/10.1016/j.bios.2013.07.044
IF: 12.545
2014-01-01
Biosensors and Bioelectronics
Abstract:Circulating tumor cells (CTCs) in the peripheral blood could serve as a surrogate marker for the diagnosis of cancer metastasis and for therapeutic evaluation. However, the separation and characterization of CTCs is technically challenging owing to the extremely low number of CTCs present. Here we developed a size-based and high-throughput microfluidic chip, which exploits filtration microchannels to isolate the relatively larger CTCs from the rest of the blood constituents. High isolation efficiency of our microfluidic chip was demonstrated with three lung cancer cell lines spiked in blood samples at an optimal flow rate of 0.4 mL/h. The average recovery rates of 96%, 95% and 92% were obtained for A549, SK-MES-1, and H446, respectively. To clinically validate the chip, we also employed it to isolate CTCs from 59 lung cancer patients. CTCs were detected in 96.7% of patients with the mean number of 18.6 cells/mL, which was significantly higher than normal controls (P<0.05). The work here indicates that the size-based microfluidic platform with the advantage of capturing tumor cells without reliance on cell surface expression markers can provide a novel, inexpensive and effective tool for CTC detection and evaluation of cancer status.